Ikeguchi Masahide
Tottori Prefectural Central Hospital, 730 Ezu, Tottori, 680-0901, Japan.
Langenbecks Arch Surg. 2016 Sep;401(6):861-6. doi: 10.1007/s00423-016-1453-9. Epub 2016 May 28.
Locally advanced carcinomas arising in the hypopharynx have been traditionally treated by resection of the hypopharynx, larynx, and cervical esophagus. However, the prognosis of these patients is still low. In the present study, we retrospectively analyzed the long-term survival of patients with locally advanced hypopharyngeal squamous cell carcinoma (HSCC) reconstructed by jejunal graft.
Between 2004 and 2014, 68 patients with HSCC were treated at Tottori University Hospital. Nine patients with synchronous esophageal cancer were excluded. We analyzed the overall survival of 59 patients with clinical stage III and IV HSCC who underwent pharyngo-laryngo-cervical esophagectomy with definitive tracheostomy followed by free jejunal graft reconstruction. Additionally, prognostic significances of preoperative patients' Glasgow prognostic score (GPS), neutrophil-lymphocyte ratio (NLR), and prognostic nutritional index were analyzed.
Postoperative complications occurred in 18.6 % of 59 patients. There were no cases of graft loss, and no patient died from complications. Preoperative poor performance status of patients was a risk factor for postoperative complications. The 5-year overall survival rate of the 59 patients was 46.1 %, and the median survival time was 28 months. In univariate and multivariate survival analyses, high GPS (1 or 2), and high NLR (≥5) were recognized as independent poor prognostic markers for patients with HSCCs.
Pharyngo-laryngo-cervical esophagectomy followed by free jejunal reconstruction was performed safely. Additional treatment, such as chemoradiotherapy, should be introduced for patients with high preoperative GPS or NLR after curative operation.
下咽局部晚期癌传统上采用下咽、喉和颈段食管切除术治疗。然而,这些患者的预后仍然较差。在本研究中,我们回顾性分析了采用空肠移植重建的下咽局部晚期鳞状细胞癌(HSCC)患者的长期生存情况。
2004年至2014年间,鸟取大学医院治疗了68例HSCC患者。排除9例同时患有食管癌的患者。我们分析了59例临床III期和IV期HSCC患者的总生存情况,这些患者接受了咽喉颈段食管切除术并进行了确定性气管切开术,随后进行了游离空肠移植重建。此外,还分析了术前患者的格拉斯哥预后评分(GPS)、中性粒细胞与淋巴细胞比值(NLR)和预后营养指数的预后意义。
59例患者中有18.6%发生了术后并发症。没有移植失败的病例,也没有患者死于并发症。患者术前身体状况较差是术后并发症的一个危险因素。59例患者的5年总生存率为46.1%,中位生存时间为28个月。在单因素和多因素生存分析中,高GPS(1或2)和高NLR(≥5)被认为是HSCC患者独立的不良预后标志物。
咽喉颈段食管切除术后游离空肠重建手术安全可行。对于根治性手术后术前GPS或NLR较高的患者,应引入放化疗等辅助治疗。